Skip to main content
Premium Trial:

Request an Annual Quote

Applera Board Okays Applied Biosystems Stock Buyback

NEW YORK, Aug. 29 (GenomeWeb News) – Applied Biosystems said today that its repurchase of up to $200 million of its common stock has been approved by the board of directors of its parent firm, Applera.

Foster City, Calif.-based Applied Biosystems said that the authorization supplements its existing authority to replenish shares issued under its employee stock benefits plan. The authorization has no time restrictions, the company added, and calls for the stock buyback to be made at times and prices management deems appropriate through open market purchases, privately negotiated transactions, tender offers, exchange offers, or otherwise.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.